跳至主要内容
临床试验/NCT02749981
NCT02749981已完成不适用

Cefazolin Dosing in Children Undergoing Cardiac Surgery With Cardiopulmonary Bypass

University Hospital, Ghent0 个研究点目标入组 56 人开始时间: 2012年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
56
主要终点
Assessment of the time during which the unbound cefazolin concentration is above the MIC of S. aureus (fT>MIC) with the current dosing regimen

研究概览

简要总结

Pharmacokinetics of cefazolin in children undergoing cardiac surgery.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
0 Days 至 15 Years(Child)
性别
All
接受健康志愿者

入选标准

  • pediatric patients undergoing cardiac surgery with cardiopulmonary bypass
  • minimum weight 1.8 kg
  • intra-arterial or intravenous access other than the drug infusion line available for blood sampling (arterial line is preferred)

排除标准

  • no catheter in place for blood sampling
  • absence of parental/patient consent
  • known hypersensitivity to cefazolin

结局指标

主要结局

Assessment of the time during which the unbound cefazolin concentration is above the MIC of S. aureus (fT>MIC) with the current dosing regimen

时间窗: 3 years

次要结局

  • Optimalisation of the cefazolin dosing regimen to aim for a target unbound cefazolin concentration above the MIC of S. aureus during surgery(3 years)

研究者

申办方类型
Other
责任方
Sponsor

相似试验